International Journal of Science and Research Archive,
Год журнала:
2024,
Номер
12(2), С. 1232 - 1235
Опубликована: Июль 30, 2024
The
filamentous
fungus
that
causes
Mucormycosis
is
a
newly
discovered
angiogenic
infection
found
in
large
quantities
and
member
of
the
Zygomycete
class's
Mucorales
order.
In
patients
undergoing
hematopoietic
allogeneic
stem
cell
transplantation,
after
candidiasis
aspergillosis,
mucormycosis
has
become
third
most
common
invasive
mycosis.
Breathing
sporangiospores
daily
need.
remarkably
low
frequency
members
nasal
mucus
indicates
airborne
contamination
either
minimal
or
mucociliary
transport
removes
spores
from
airway
mucus.
this
review
research,
new
approaches
to
assessing
relationships
among
host,
fungus,
antifungal
drugs
are
provided.
Aerosols
other
novel
delivery
methods
might
also
aid
treatment
mucormycosis.
Scientific Reports,
Год журнала:
2024,
Номер
14(1)
Опубликована: Фев. 1, 2024
Abstract
Infections,
such
as
mucormycosis,
often
result
from
inhaling
sporangiospore
present
in
the
environment.
Surprisingly,
extent
of
airborne
Mucormycetes
concentrations
remains
inadequately
explored.
This
study
aimed
to
assess
influence
UV
radiation
on
microbial
populations
and
spore
levels
within
a
hospital
environment
northern
Iran.
A
comprehensive
dataset
comprising
298
air
samples
collected
both
indoor
outdoor
settings
was
compiled.
The
culture
conducted
using
Blood
Agar
Dichloran
Rose
Bengal
Chloramphenicol
(DRBC)
media,
with
included
for
fungal
agents
bacterial.
Before
treatment,
average
count
ranged
0
26.4
±
25.28
CFU
m
−3
,
2.24
3.22
117.24
27.6
bacterial
29.03
9.9
359.37
68.50
.
Following
irradiation,
averages
were
follows:
7.85
6.8
16.58
4.79
154.98
28.35
0.38
0.65
43.92
6.50
study,
notably
marks
pioneering
use
light
mitigate
counts
northeastern
Iran,
contributing
advancement
environmental
health
safety
practices
settings.
Heliyon,
Год журнала:
2024,
Номер
10(9), С. e29967 - e29967
Опубликована: Апрель 19, 2024
The
COVID-19
pandemic
has
become
a
significant
global
issue
in
terms
of
public
health.
While
it
is
largely
associated
with
respiratory
complications,
recent
reports
indicate
that
patients
also
experience
neurological
symptoms
and
other
health
issues.
objective
this
study
to
examine
the
network
protein-protein
interactions
(PPI)
between
SARS-CoV-2
proteins
human
host
proteins,
pinpoint
central
genes
within
implicated
disease
pathology,
assess
their
viability
as
targets
for
drug
development.The
adopts
network-based
approach
construct
29
interacting
2896
176
being
identified
all
viral
proteins.
Gene
ontology
pathway
analysis
these
revealed
role
biological
processes
such
translation,
mRNA
splicing,
ribosomal
pathways.
We
further
EEF2,
RPS3,
RPL9,
RPS16,
RPL11
top
5
most
connected
hub
disease-causing
network,
among
each
other.
These
were
found
be
involved
pathways
cytoplasmic
translation.
Further
disease-gene
interaction
was
prepared
investigate
disorders
understand
condition
comorbidity
patients.
13
molecules
having
genes,
estradiol
emerged
potential
target
Our
provides
valuable
insights
using
highlights
molecular
basis
manifestation
proposes
repurposing.As
continues
evolve,
anticipated
investigating
will
remain
critical
area
focus
researchers
globally,
particularly
addressing
challenges
posed
by
specific
variants
future.
PLoS ONE,
Год журнала:
2023,
Номер
18(4), С. e0284301 - e0284301
Опубликована: Апрель 14, 2023
The
world
has
witnessed
of
many
pandemic
waves
SARS-CoV-2.
However,
the
incidence
SARS-CoV-2
infection
now
declined
but
novel
variant
and
responsible
cases
been
observed
globally.
Most
population
received
vaccinations,
immune
response
against
COVID-19
is
not
long-lasting,
which
may
cause
new
outbreaks.
A
highly
efficient
pharmaceutical
molecule
desperately
needed
in
these
circumstances.
In
present
study,
a
potent
natural
compound
that
could
inhibit
3CL
protease
protein
was
found
with
computationally
intensive
search.
This
research
approach
based
on
physics-based
principles
machine-learning
approach.
Deep
learning
design
applied
to
library
compounds
rank
potential
candidates.
procedure
screened
32,484
compounds,
top
five
hits
estimated
pIC
50
were
selected
for
molecular
docking
modeling.
work
identified
two
hit
CMP4
CMP2,
exhibited
strong
interaction
using
simulation.
These
demonstrated
catalytic
residues
His41
Cys154
protease.
Their
calculated
binding
free
energies
MMGBSA
compared
those
native
inhibitor.
Using
steered
dynamics,
dissociation
strength
complexes
sequentially
determined.
conclusion,
comparative
performance
inhibitors
as
promising
candidate.
can
be
in-vitro
experiment
validation
its
inhibitory
activity.
Additionally,
methods
used
identify
sites
enzyme
target
sites.
Frontiers in Neurology,
Год журнала:
2022,
Номер
13
Опубликована: Май 4, 2022
Rhino-orbital
cerebral
mucormycosis
(ROCM)
is
a
rare,
invasive,
and
fatal
fungal
disease.
Due
to
the
lack
of
specific
clinical
manifestations
adequate
auxiliary
examinations,
patients
are
easily
misdiagnosed
in
early
stage.
Early
diagnosis
timely
therapy
essential
for
successful
treatment.
Infectious Disorders - Drug Targets,
Год журнала:
2023,
Номер
24(1)
Опубликована: Авг. 23, 2023
Mucormycosis
is
a
serious
and
invasive
fungal
infection
caused
by
Mucorales
fungi.
This
review
article
provides
concise
overview
of
the
pathogenesis,
epidemiology,
microbiology,
diagnosis
mucormycosis.
The
introduction
section
highlights
key
microbiological
properties
pathogen
delves
into
underlying
mechanisms
mucormycosis
including
invasion
proliferation
fungus
within
host.
description
disease
focuses
on
epidemiology
mucormycosis,
its
incidence,
risk
factors,
geographical
distribution.
It
also
explores
specific
context
about
COVID-19
diabetes
mellitus,
highlighting
increased
susceptibility
observed
in
individuals
with
these
conditions.
A
case
study
illustrates
clinical
manifestations
challenges
associated
emphasizing
importance
early
detection.
Additionally,
discusses
significance
assessment,
radiological
imaging,
tests
for
accurate
timely
detection
infection.
Regarding
treatment,
covers
various
therapeutic
approaches,
antifungal
therapy,
surgical
interventions,
management
predisposing
limitations
treatment
options
are
addressed.
aims
to
provide
comprehensive
understanding
equipping
healthcare
professionals
valuable
insights
diagnostic
strategies.
By
enhancing
knowledge
awareness
this
infection,
can
improve
patient
outcomes
through
appropriate
management.
Current Pharmaceutical Biotechnology,
Год журнала:
2023,
Номер
24(13), С. 1645 - 1656
Опубликована: Март 21, 2023
Abstract:
The
COVID-19
pandemic
has
shown
an
adverse
effect
worldwide,
but
in
India,
it
been
observed
during
the
second
wave
that
people
who
recovered
from
infection
developed
a
secondary
because
grows
tandem
with
treatment.
Meanwhile,
news
of
new
deadly
fungus
surfaced
known
as
Mucormycosis
(Black
fungus).
is
fungal
invades
blood
vessels
and
caused
by
Mucormycetes,
group
fungi.
Due
to
post-pandemic
many
bacterial
diseases
have
affected
population.
reason
behind
frequent
development
opportunistic
infections
like
mucormycosis
use
steroids,
oxygen
masks,
antibiotics
throughout
treatment
critically
severely
ill
patients
COVID-19.
Inhaling
filamentous
fungi
natural
environment
lack
supportive
care
units
can
be
risk
factor
for
mucormycosis.
It
usually
found
are
immunocompromised.
more
common
HIV/AIDS,
COVID-19,
congenital
bone
marrow
disease,
viral
diseases,
malignancies,
severe
burns,
irregularly
or
untreated
treated
diabetes.
This
review
emphasizes
triggers
may
precipitate
related
corticosteroids,
recent
epidemiology,
incidence
was
diagnosed
identified
using
variety
cutting-edge
medical
techniques,
including
clinical
diagnosis,
histopathology,
serology.
Many
methods,
such
antifungal
medications
therapies,
also
successfully
used.
mortality
rate,
however,
remains
high
due
aggressive
surgical
excision
debridement
early
diagnosis.
Journal of Biochemical and Molecular Toxicology,
Год журнала:
2023,
Номер
37(9)
Опубликована: Июнь 22, 2023
During
the
period
of
COVID-19,
occurrences
mucormycosis
in
immunocompromised
patients
have
increased
significantly.
Mucormycosis
(black
fungus)
is
a
rare
and
rapidly
progressing
fungal
infection
associated
with
high
mortality
morbidity
India
as
well
globally.
The
causative
agents
for
this
are
collectively
called
mucoromycetes
which
members
order
Mucorales.
diagnosis
needs
to
be
performed
soon
occurrence
clinical
symptoms
differs
types
Mucorales
infection.
Imaging
techniques
magnetic
resonance
imaging
or
computed
tomography
scan,
culture
testing,
microscopy
approaches
diagnosis.
After
confirmed,
rapid
action
needed
treatment
form
antifungal
therapy
surgery
depending
upon
severity
Delaying
declines
chances
survival.
In
therapy,
there
two
first-line
(monotherapy)
combination
therapy.
Amphotericin
B
(1)
isavuconazole
(2)
drugs
choice
mucormycosis.
Salvage
posaconazole
(3)
deferasirox
(4)
another
approach
who
not
responsible
any
other
Adjunctive
also
used
along
involves
hyperbaric
oxygen
cytokine
There
some
like
VT-1161
(5)
APX001A
(6),
Colistin,
SCH
42427,
PC1244
that
under
trials.
Despite
all
these
approaches,
none
can
100%
successful
giving
results.
Therefore,
new
medications
favorable
little
side
effects
required
Mucormycosis
is
an
opportunistic
fungal
infection
caused
by
the
zygomycetes
Mucor
and
Rhizopus.
Most
documented
conditions
risk
factors
that
predispose
to
mucormycosis
are
uncontrolled
diabetes
mellitus
(DM),
with
or
without
ketoacidosis,
hematological
malignancies
(HM),
transplantation,
immunosuppression,
chronic
sinusitis.
Pulmonary
empyema
secondary
in
coronavirus
disease
2019
(COVID-19)-infected
patients
rarely
documented.
Here
we
present
extremely
rare
case
of
pulmonary
complicated
bronchocutaneous
fistula
a
human
immunodeficiency
virus
(HIV)-infected
patient
setting
acute
COVID-19
infection.
BMC Infectious Diseases,
Год журнала:
2023,
Номер
23(1)
Опубликована: Март 31, 2023
Abstract
Background
Acute
invasive
fungal
rhinosinusitis
(AIFRS)
is
a
fatal
infection
associated
with
high
morbidity
and
mortality.
Although
it
rare
disease,
upsurge
of
AIFRS
was
noticed
during
the
second
wave
COVID-19
disease.
Early
diagnosis
management
cornerstone
for
good
outcomes.
However,
challengeable
especially
in
developing
countries
due
to
limited
resources
prices
antifungal
agents.
No
previous
studies
have
been
conducted
evaluate
outcomes
Syria.
The
purpose
this
study
report
results
low
doses
liposomal
amphotericin
B
our
tertiary
hospital
Methods
cases
were
followed
through
prospective
observational
between
January
2021
July
2022.
required
medical
data
collected
each
individual.
Three-month
mortality
rate
studied.
SPSS
v.26
used
perform
statistical
analysis.
Pearson
Chi-square
test
associations
different
variables
Survival
curves
plotted
by
Kaplan–Meier
compare
survival
probability.
Log
Rank
(Mantel-Cox)
Cox
regression
factors
affecting
within
follow
up
period.
Results
Of
70
cases,
36
(51.4%)
males
34
(48.6%)
females.
mean
age
patients
52.5
years
old.
most
common
underlying
risk
factor
diabetes
mellitus
(84.3%).
dose
ranged
2–3
mg/kg
per
day.
overall
3-month
35.7%.
Significant
association
found
following
variables:
Age,
orbital
involvement,
stage,
comorbidity.
Conclusion
close
other
studies.
worse
than
comparable
selected
(older
ages,
involved
orbits,
advanced
stages,
chronic
immunodeficiency).
Therefore,
could
be
less
effective
such
are
recommended.
Background:
The
aim
of
this
systematic
review
literature
is
to
know
the
characteristics
patients
with
Covid-19
related
mucormycosis,
associated
comorbidities
as
well
use
steroids
in
people
Covid-19,
site
size
and
location
substance
loss
caused
by
surgical
debridement,
contribution
maxillofacial
rehabilitation
survivors.Methods:
Using
keywords,
studies
were
selected
from
following
databases:
MEDLINE
(via
PubMed),
Science
Direct
Google
Scholar,
including
publications
2019
until
February
2022.They
filtered
title,
abstract,
full
text.Results:
Among
706
records
identified
databases,
28
considered
relevant
met
eligibility
criteria,
21
case
reports
7
series.These
included
69
a
mean
age
50.4
years,
different
countries.Conclusions:
Despite
limitations
our
review,
we
can
conclude
that
mucormycosis
an
opportunistic
deadly
fungal
illness
uncontrolled
diabetes
individuals
who
are
immunocompromised.Physicians
should
be
conscious
red
flags
such
previous
infection,
particularly
those
hospitalized
given
high-flow
oxygen
therapy
high-dose
long-term
steroids;
metabolic
diseases.